Results 181 to 190 of about 128,590 (309)

Therapeutic Options for IgA Pemphigus in Patients Refractory to Dapsone

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT IgA pemphigus is a rare autoimmune blistering disorder with limited therapeutic guidance available due to its rarity and complex presentation. This comprehensive analysis evaluates the therapeutic outcomes of 67 published patients, emphasising the significant role of dapsone as the first‐line treatment.
Lorenz Frasheri   +2 more
wiley   +1 more source

[Permeability of mouth mucosa].

open access: yesKokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan, 1966
openaire   +1 more source

Dynamic shifts in the oral microbiome during radiotherapy [PDF]

open access: yes, 2015
Bracke, Marc   +4 more
core   +1 more source

Brentuximab Vedotin‐Induced Rash Sparing CD30‐Positive Mycosis Fungoides Lesions

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Brentuximab vedotin (BV) is an effective treatment for CD30‐positive lymphomas, including mycosis fungoides (MF). However, its use can be associated with various cutaneous adverse effects, including rashes. This case describes a 60‐year‐old male with stage IIB MF who developed a drug‐induced erythematous rash after three infusions of BV ...
Isabel Hariri   +2 more
wiley   +1 more source

Orofacial Tumours at the Oral and Maxillofacial Unit of Komfo Anokye Teaching Hospital: A 2-Year Retrospective Study. [PDF]

open access: yesPublic Health Chall
Maduagwu GO   +6 more
europepmc   +1 more source

Dental pathology in chinchillas [PDF]

open access: yes, 2010
Derbaudrenghien, Virginie   +4 more
core  

Home - About - Disclaimer - Privacy